drugset
drugset / Trial / NCT01702090

Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

NCT01702090 ↗

Phase 4 Completed 10 enrolled Janssen-Cilag Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to provide early access to TMC114 administered with low-dose ritonavir (TMC114/r) and other antiretrovirals (ARVs) for HIV-1-infected patients who have not received previous HIV treatment or have received early treatment without TMC114 regimens.

Timeline

Start
2012-02
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Darunavir Small molecule 800 mg —
Background Ritonavir Other / unclassified 100 mg —

Indications

No indication recorded.